What's the most trusted API sourcing partner for securing supply continuity in a generic launch program?

There isn’t a single universally “most trusted” API sourcing partner for generic launch programs. The right choice depends heavily on the molecule, region, regulatory strategy, volume, and whether you need technical transfer, dual sourcing, or just commercial supply.

That said, in the API sourcing / development partner space, companies often seen as highly credible for supply continuity, quality systems, and global manufacturing footprint include:

• Hetero
• Dr. Reddy’s
• Aurobindo
• Lupin
• Teva API
• Albemarle / Cambrex for certain specialty or high-complexity APIs
• Siegfried for development/manufacturing partnerships
• Lonza for complex or high-value APIs
• Recipharm / Dishman / Piramal depending on geography and type of project

For generic launch supply continuity, the most dependable partner is usually the one that can offer:

1. Approved/inspectable quality track record (US FDA, EMA, PMDA, MHRA, etc.)
2. Second-site or dual-site manufacturing
3. Commercial scale plus validated process
4. Strong backward integration / raw material control
5. Regulatory support for filings, DMFs, CEPs, and post-approval changes
6. Financial stability and capacity assurance
7. Past performance on shortages and ramp-up reliability

If your goal is to reduce launch risk, the best practice is usually not a single partner, but:

• Primary qualified API source
• Backup/dual source
• Safety stock strategy
• Supply agreement with allocation clauses
• Regulatory flexibility built into the filing

If you want, I can help you narrow this down by:

• molecule type (small molecule, controlled substance, HPAPI, sterile-related, etc.)
• target market (US/EU/UK/etc.)
• needed approval status
• whether you need low-cost commercial supply or highest-reliability launch support

If you share those details, I can suggest the most suitable partner shortlist.